Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Sinarmas Multiartha Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp252 (kapitalisasi pasar 172,82 M, volume 24 jam 218,7 rb), sedangkan Sinarmas Multiartha Tbk. diperdagangkan di Rp20.600 (kapitalisasi pasar 131,17 T, volume 24 jam 2,5 rb). Perbedaan utamanya: Sinarmas Multiartha Tbk. jauh lebih besar — sekitar 759× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (218,7 rb vs 2,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SMMA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 131,17 T |
Volume | 218,7 rb | 2,5 rb |
Lot | 2,19 rb | 25 |
Perputaran | 53,51 jt | 50,88 jt |
Harga Rata-rata | 244,66 | 20.351 |
Nilai Transaksi | 53,51 jt | 50,88 jt |
Harga Ekuilibrium Indikatif | 252 | 20.600 |
Volume Ekuilibrium Indikatif | 48 | 2 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Selengkapnya di halaman SMMA →